Patent · US Active

Pharmaceutical compounds

US7785566B2 · kind B2 · utility

0Cited by

2References

6Claims

0Family size

Assignee

GE HEALTHCARE LIMITED · GB

Inventors

Alan Cuthbertson · San Jose, US
Bard Indrevoll · Oslo, NO
Morten Eriksen · Oslo, NO

Key dates

Filing date	Nov 5, 2004
Grant date	Aug 31, 2010
Priority date	—
Expiry date	Jan 1, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K7/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention comprises pharmaceuticals of formula (I) Z-(L)n-V, wherein V denotes a peptide, L denotes an optional linker, Z denotes a group that optionally can carry an imaging moiety M, n denotes 0 or 1. The pharmaceuticals are active as therapeutic agents for the treatment of heart failure, cardiac arrhythmias and diseases were fibrosis is prominent such as COPD, liver fibrosis and atherosclerosis and are also useful as diagnostic agents for the diagnosis of heart failure and diseases were fibrosis is prominent such as COPD, liver fibrosis and atherosclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.